Coherus BioSciences (CHRS)
(Delayed Data from NSDQ)
$1.39 USD
-0.22 (-13.66%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $1.42 +0.03 (2.16%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | -0.30 |
EPS Last Quarter | -0.38 |
Last EPS Surprise | -171.43% |
ABR | 1.60 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.14 |
Next Year | -0.25 |
EPS (TTM) | -1.59 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 57.37M | 61.71M | 260.78M | 333.82M |
# of Estimates | 2 | 2 | 3 | 3 |
High Estimate | 62.00M | 65.00M | 272.00M | 357.00M |
Low Estimate | 52.73M | 58.41M | 250.33M | 305.00M |
Year ago Sales | 58.72M | 74.57M | 257.24M | 260.78M |
Year over Year Growth Est. | -2.31% | -17.25% | 1.37% | 28.01% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.21 | -0.08 | -0.63 | 0.06 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.26 | -0.11 | -0.78 | -0.12 |
High Estimate | -0.15 | -0.04 | -0.48 | 0.23 |
Low Estimate | -0.26 | -0.11 | -0.78 | -0.12 |
Year ago EPS | -0.38 | -0.27 | -1.98 | -0.63 |
Year over Year Growth Est. | 44.74% | 70.37% | 68.18% | 108.73% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.30 | -0.17 | -1.14 | -0.25 |
7 Days Ago | -0.30 | -0.17 | -1.14 | -0.25 |
30 Days Ago | -0.30 | -0.17 | -1.14 | -0.25 |
60 Days Ago | -0.10 | -0.01 | -0.37 | 0.41 |
90 Days Ago | -0.10 | -0.01 | -0.56 | 0.11 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.30 | -0.17 | -1.14 | -0.25 |
Zacks Consensus Estimate | -0.30 | -0.17 | -1.14 | -0.25 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.38 | -0.72 | -0.38 | -0.49 | NA |
Estimate | -0.14 | -0.33 | -0.45 | -0.66 | NA |
Difference | -0.24 | -0.39 | 0.07 | 0.17 | -0.10 |
Surprise | -171.43% | -118.18% | 15.56% | 25.76% | -62.07% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more